Aberrant P15, P16, P53, and DAPK Gene Methylation in Myelomagenesis: Clinical and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2016.08.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic Significance of DAPK Promoter Methylation in Lymphoma: A Meta-Analysis

PLoS ONE
Multidisciplinary
2019English

Infrequent Methylation of CDKN2A(MTS1/p16) and Rare Mutation of Both CDKN2A and CDKN2B(MTS2/p15) in Primary Astrocytic Tumours

British Journal of Cancer
Cancer ResearchOncology
1997English

Mechanistic and Prognostic Significance of Aberrant Methylation in the Molecular Pathogenesis of Human Hepatocellular Carcinoma

Journal of Clinical Investigation
Medicine
2007English

Aberrant Gene Promoter Methylation Marking Disease Progression in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Screening the Methylation Status of DAPK Gene Using Plant Extracts in a Lung Cancer Cell Line

Advances in Biotechnology & Microbiology
2017English

Clinical Significance of Aberrant DEUP1 Promoter Methylation in Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Aberrant DNA Methylation of P16, MGMT, and hMLH1 Genes in Combination With MTHFR C677T Genetic Polymorphism in Esophageal Squamous Cell Carcinoma

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Prognostic Significance of Aberrant CpG Islands Methylation in Human Follicular and Diffuse Large B-Cell Lymphoma

English

Detection of Aberrant DNA Methylation in Unique Prader — Willi Syndrome Patients and Its Diagnostic Implications

Human Molecular Genetics
MedicineGeneticsMolecular Biology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy